SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-15-291724
Filing Date
2015-08-14
Accepted
2015-08-14 16:05:15
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d53046ds3.htm S-3 284198
2 EX-4.3 d53046dex43.htm EX-4.3 295029
3 EX-4.4 d53046dex44.htm EX-4.4 315807
4 EX-4.5 d53046dex45.htm EX-4.5 34525
5 EX-4.6 d53046dex46.htm EX-4.6 35060
6 EX-5.1 d53046dex51.htm EX-5.1 32327
7 EX-23.1 d53046dex231.htm EX-23.1 1670
8 GRAPHIC g53046ex5_1pg001.jpg GRAPHIC 16720
9 GRAPHIC g53046wilmerhale_logo.jpg GRAPHIC 2770
  Complete submission text file 0001193125-15-291724.txt   1026834
Mailing Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139
Business Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139 617-551-9600
Cerulean Pharma Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-206396 | Film No.: 151055673
SIC: 2834 Pharmaceutical Preparations